NO ATC L01EB02 · updated 2 Nov 2026
Erlotinib shortage in Norway
Is there an Erlotinib shortage in Norway?
Yes. As of 2 Nov 2026, 3 Erlotinib products are reported short in Norway, the first since 1 Feb 2026. The company estimate for the return is 30 Nov 2026. Main reason: increased demand.
Also short in Canada, Italy, Belgium, Sweden. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Tarceva 100 mg tablett, filmdrasjert, 30 stk blisterpakning | Cheplapharm Registration Gmbh | 1 Feb 2026 | 30 Nov 2026 | Increased demand Uventet økt etterspørsel |
| NO | Tarceva 150 mg tablett, filmdrasjert, 30 stk blisterpakning | Cheplapharm Registration Gmbh | 20 Mar 2026 | 30 Nov 2026 | Increased demand Uventet økt etterspørsel |
| NO | Tarceva 25 mg tablett, filmdrasjert, 30 stk blisterpakning | CHEPLAPHARM Registration GmbH | 26 Jun 2026 | 30 Nov 2026 | Increased demand Uventet økt etterspørsel |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).